Robert Gray is Professor of Respiratory Medicine at the School of Infection & Immunity and an Honorary Consultant Respiratory Physician at NHS GGC. He completed training in respiratory medicine in Edinburgh and then held consecutive intermediate (Wellcome) and senior (NRS/CSO) fellowships prior to his appointment in Glasgow.

1. Spontaneous lung repair processes in the CF and other lung diseases. We are using ex-vivo models to study how lung damage occurs and repairs. By understanding how spontaneous tissue repair occurs, we will be able to develop new treatments to support the repair of damaged lung tissue.

2. Inflammation in lung disease: By mapping out the inflammation process in CF using tissue from people with CF and other lung diseases, we will allow the development of future anti-inflamatory treatments to be driven by scientific understanding. We will use new technologies, such as single cell RNA sequecung and spatial biology, to achieve these aims.

3. Defining the role of calprotectin in health and disease in the lung and other tissues: The Gray Lab has studied S100 proteins in the lung for the past 15 years; firstly, as biomarkers, and now as a potential drug target.